MRI-guided radiation aims to slash side effects in endometrial cancer
NCT ID NCT07514325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to deliver radiotherapy for endometrial cancer after surgery. Using real-time MRI guidance, doctors can target radiation more accurately and reduce damage to nearby organs like the bowel and bladder. About 61 women will receive five high-dose sessions over two and a half weeks. The main goal is to see if this approach causes fewer short-term side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MR-guided adaptive radiotherapy (MGART)
- What this could lead to
- If successful, this could offer a more precise and safer radiotherapy option for endometrial cancer, reducing bowel and bladder side effects.
- What could go wrong
- This is a small, early-phase study (61 participants) testing safety, not yet proven to work better than standard treatment. Side effects may still occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Could gentle yoga and breathing ease Cancer's lingering toll?